f Meet the Editor-in-Chief

References

1. Di StefanoM. MasoniS. BononiG. Poli G, Galati S, Gado F, Manzi S, Vagaggini C, Brai A, Caligiuri I, Asif K, Rizzolio F, Macchia M, Chicca A, Sodi A, Di Bussolo V, Minutolo F, Meier P, Gertsch J, Granchi C, Dreassi E, Tuccinardi T. Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors.Eur. J. Med. Chem.2024263115916
   [Google Scholar]
2. GalatiS. Di StefanoM. MacchiaM. PoliG. TuccinardiT. MolBook UNIPI - create, manage, analyze and share your chemical data for free.J Chem Inf.2023631339773982
   [Google Scholar]
3. PoliG. DemontisG.C. SodiA. Saba A, Rizzo S, Macchia M, Tuccinardi T. An in silico toolbox for the prediction of the potential pathogenic effects of missense mutations in the dimeric region of hRPE65.J. Enzyme Inhib. Med. Chem.20233812162047
   [Google Scholar]
4. BononiG. Di StefanoM. PoliG. Ortore G, Meier P, Masetto F, Caligiuri I, Rizzolio F, Macchia M, Chicca A, Avan A, Giovannetti E, Vagaggini C, Brai A, Dreassi E, Valoti M, Minutolo F, Granchi C, Gertsch J, Tuccinardi T. Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a new class of benzylpiperidine derivatives.J. Med. Chem.2022651071187140
   [Google Scholar]
5. TuccinardiT. What is the current value of MM/PBSA and MM/GBSA methods in drug discovery? Exp.Opin. on Drug Disc.2021161112331237
   [Google Scholar]
6. BononiG. TuccinardiT. RizzolioF. GranchiC. α/β-Hydrolase Domain (ABHD) inhibitors as new potential therapeutic options against lipid-related diseases.J. Med. Chem.2021641497599785
   [Google Scholar]
7. BononiG. TonariniG. PoliG. Barravecchia I, Caligiuri I, Macchia M, Rizzolio F, Demontis GC, Minutolo F, Granchi C, Tuccinardi T. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.Eur. J. Med. Chem.2021223113679
   [Google Scholar]
8. GranchiC. BononiG. FerrisiR. Gori E, Mantini G, Glasmacher S, Poli G, Palazzolo S, Caligiuri I, Rizzolio F, Canzonieri V, Perin T, Gertsch J, Sodi A, Giovannetti E, Macchia M, Minutolo F, Tuccinardi T, Chicca A. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.Eur. J. Med. Chem.2021209112857
   [Google Scholar]
9. PoliG. GalatiS. MartinelliA. SupuranC.T. TuccinardiT. Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors.J. Enzyme Inhib. Med. Chem.2020351365371
   [Google Scholar]
10. GranchiC. LapilloM. GlasmacherS. Bononi G, Licari C, Poli G, El Boustani M, Caligiuri I, Rizzolio F, Gertsch J, Macchia M, Minutolo F, Tuccinardi T, Chicca A. Optimization of a benzoylpiperidine class identifies a highly potent and selective reversible monoacylglycerol lipase (MAGL) inhibitor.J. Med. Chem.201962419321958
    [Google Scholar]